PIPELINE EMBOLIZATION DEVICE
Report
- Report Number
- 2029214-2015-00036
- Event Type
- Death
- Date Received
- January 9, 2015
- Report Date
- December 12, 2014
- Manufacturer
- COVIDIEN
- Product Code
- OUT
- PMA / PMN Number
- P100018.S004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- OTHER
Narratives
THE LOT HISTORY RECORD REVIEW WAS NOT POSSIBLE SINCE THE LOT NUMBERS WERE NOT REPORTED. THE DEVICES WILL NOT BE RETURNED FOR ANALYSIS AS THEY WERE IMPLANTED IN THE PATIENT; THEREFORE, THE EVENT CAUSES COULD NOT BE DETERMINED. THE OTHER DEVICES INVOLVED IN THE OTHER EVENTS ARE AS FOLLOWS: (B)(4).
INFORMATION RECEIVED FROM THE ARTICLE: RAYCHEV R, TATESHIMA S, VINUELA F, ET AL. ABSTRACT W MP31: THROMBOTIC AND HEMORRHAGIC COMPLICATIONS AFTER PIPELINE EMBOLIZATION - A PLATELET AGGREGATION AND TRANSCRANIAL (B)(6) STUDY. STROKE. 2014; 45: AWMP31 A TOTAL OF 46 CONSECUTIVE PATIENTS UNDERWENT 48 PIPELINE EMBOLIZATION PROCEDURES. ALL PATIENTS RECEIVED DOUBLE ANTIPLATELET THERAPY WITH CLOPIDOGREL 75MG AND ASPIRIN 325MG DAILY FOR AT LEAST 3 DAYS PRIOR TO THE PLANNED PROCEDURE. PLATELET AGGREGATION TESTING WAS PERFORMED IN 41 PROCEDURES. BASED ON THE INITIAL ADP % INHIBITION, PATIENTS WERE DIVIDED IN 3 GROUPS IN THE PRESENT STUDY: 1) POOR RESPONDERS: 50%, 2) SATISFACTORY RESPONDERS: 50-75%, AND 3) OVER-RESPONDERS: 75% SIX PATIENTS EXPERIENCED SYMPTOMATIC THROMBOTIC COMPLICATIONS AND 3 PATIENTS EXPERIENCED A SYMPTOMATIC ICH (INTRACEREBRAL HEMORRHAGE) WHICH OCCURRED IN A REMOTE VASCULAR TERRITORY IN REFERENCE TO THE TREATED ANEURYSM, ONE OF WHICH WAS FATAL. NO FURTHER INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 21213 | PIPELINE EMBOLIZATION DEVICE | INTRACRANIAL ANEURYSM FLOW DIVERTER | OUT | COVIDIEN | NOT REPORTED | NOT REPORTED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Death| S |